| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.50B | 67.69B | 69.54B | 67.94B | 60.54B | 54.95B |
| Gross Profit | 21.68B | 21.40B | 21.93B | 21.35B | 17.60B | 15.68B |
| EBITDA | 11.60B | 8.84B | 11.40B | 9.46B | 6.98B | 5.88B |
| Net Income | 5.65B | 5.40B | 6.05B | 5.41B | 3.41B | 2.51B |
Balance Sheet | ||||||
| Total Assets | 75.24B | 76.48B | 74.41B | 72.37B | 62.86B | 55.58B |
| Cash, Cash Equivalents and Short-Term Investments | 10.63B | 13.86B | 10.12B | 7.86B | 7.41B | 7.21B |
| Total Debt | 14.40B | 12.98B | 14.62B | 14.88B | 15.77B | 12.41B |
| Total Liabilities | 29.34B | 27.37B | 29.75B | 31.79B | 29.55B | 26.47B |
| Stockholders Equity | 44.99B | 48.07B | 43.78B | 39.77B | 32.51B | 28.34B |
Cash Flow | ||||||
| Free Cash Flow | 318.13M | 6.16B | 3.48B | 3.65B | 310.31M | 575.51M |
| Operating Cash Flow | 878.85M | 7.62B | 6.10B | 6.24B | 2.22B | 2.81B |
| Investing Cash Flow | -308.16M | 282.11M | -351.28M | -2.04B | -2.00B | -2.30B |
| Financing Cash Flow | -540.05M | -4.25B | -3.50B | -3.42B | -261.17M | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥159.12B | 14.32 | ― | 3.23% | 5.32% | -3.12% | |
79 Outperform | ¥59.65B | 10.81 | ― | 1.12% | 18.83% | 55.54% | |
78 Outperform | ¥45.41B | 9.33 | ― | 3.21% | 8.90% | 35.83% | |
75 Outperform | ¥53.44B | 9.50 | ― | 1.94% | -2.66% | -9.83% | |
72 Outperform | ¥70.69B | 11.56 | ― | 2.31% | 3.34% | -8.24% | |
69 Neutral | ¥26.81B | 12.06 | ― | 2.89% | 7.91% | 2.84% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |